EE293 Diagnostic Hospitalization and Associated Costs in Patients with Amyloid Light-Chain Amyloidosis

Autor: TP Quock, E Chang, K Bognar, MH Tarbox, A D'Souza, M Broder

Publikováno v: Value in Health. 25:S391

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e3af535dab08c3a1e30767d800f72c82
https://doi.org/10.1016/j.jval.2022.04.538

Work Productivity And Impairment Among Patients With Light Chain Amyloidosis

Autor: KL McCausland, Martha S. Bayliss, S Guthrie, Michelle K. White, TP Quock, M Yokota

Publikováno v: Value in Health. 20:A562

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::560191f42fbbdaff723536760524b465
https://doi.org/10.1016/j.jval.2017.08.926

Health-Related Quality of Life Instruments for Clinical Trials in AL Amyloidosis: Report from the Amyloidosis Forum HRQOL Working Group.

Autor: Rizio AA; QualityMetric Incorporated, LLC, Johnston, RI, USA., White MK; QualityMetric Incorporated, LLC, Johnston, RI, USA., D'Souza A; Froedtert & MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA., Hsu K; Amyloidosis Research Consortium, Boston, MA, USA., Schmitt P; Amyloidosis Support Groups, Inc, Wood Dale, IL, USA., Quock TP; Prothena Biosciences Inc, South San Francisco, CA, USA., Signorovitch J; Epidemiology and Biostatistics, Analysis Group, Inc, Boston, MA, USA., Lousada I; Amyloidosis Research Consortium, Boston, MA, USA., Sanchorawala V; Amyloidosis Center, Boston University School of Medicine and Boston Medical Center, Boston, MA, USA.

Publikováno v: Patient related outcome measures [Patient Relat Outcome Meas] 2023 May 18; Vol. 14, pp. 153-169. Date of Electronic Publication: 2023 May 18 (Print Publication: 2023).

Diagnostic amyloid light chain amyloidosis hospitalizations associated with high acuity and cost: analysis of the Premier Healthcare Database.

Autor: D'Souza A; Medical College of Wisconsin, Milwaukee, WI 53226, USA., Broder MS; Real World Evidence, PHAR (Partnership for Health Analytic Research), Beverly Hills, CA 90212, USA., Bognar K; Real World Evidence, PHAR (Partnership for Health Analytic Research), Beverly Hills, CA 90212, USA., Chang E; Real World Evidence, PHAR (Partnership for Health Analytic Research), Beverly Hills, CA 90212, USA., Tarbox MH; Real World Evidence, PHAR (Partnership for Health Analytic Research), Beverly Hills, CA 90212, USA., Quock TP; Health Economics and Outcomes Research, Prothena Biosciences Inc., South San Francisco, CA 94080, USA.

Publikováno v: Journal of comparative effectiveness research [J Comp Eff Res] 2022 Dec; Vol. 11 (17), pp. 1225-1230. Date of Electronic Publication: 2022 Oct 21.

Content Validation of the ATTR Amyloidosis Patient Symptom Survey: Findings from Patient and Clinician Cognitive Debriefing Interviews.

Autor: Rizio AA; Optum Life Sciences, Patient Insights, Johnston, RI, USA., Broderick LE; Optum Life Sciences, Patient Insights, Johnston, RI, USA., White MK; Optum Life Sciences, Patient Insights, Johnston, RI, USA., Quock TP; Prothena Biosciences Inc, South San Francisco, CA, USA.

Publikováno v: Patient related outcome measures [Patient Relat Outcome Meas] 2020 Aug 26; Vol. 11, pp. 149-160. Date of Electronic Publication: 2020 Aug 26 (Print Publication: 2020).